NextCell Pharma AB (FRA:65G) Shares Outstanding (Diluted Average) : 73.09 Mil (As of Aug. 2024)

NextCell Pharma AB Shares Outstanding (Diluted Average) Chart

NextCell Pharma AB Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24
Shares Outstanding (Diluted Average)		Get a 7-Day Free Trial					33.04	43.53	43.53	43.53	73.09

NextCell Pharma AB Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Shares Outstanding (Diluted Average)	Get a 7-Day Free Trial															43.53	43.53	43.53	34.38	73.09

NextCell Pharma AB Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

NextCell Pharma AB  (FRA:65G) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

NextCell Pharma AB Shares Outstanding (Diluted Average) Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB Business Description